Quarterly report · Q2
4548.TEDINET S100PK15
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥34.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥6.0bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.4bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥6.4bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.0bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥5.0bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥77.8bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥75.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥76.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.9bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥69.8bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥66.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥68.8bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥24.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥268m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥870m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥563m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥56.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.72 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.07 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.28 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.7% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥16.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥16.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥4.9bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥20.5bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥20.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥6.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 524
| Item | Context | Value | Unit |
|---|---|---|---|
| Work in process | Prior1YearInstant | 2610000000 | JPY |
| Work in process | CurrentQuarterInstant | 2487000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 3408000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 3573000000 | JPY |
| Other ca | Prior1YearInstant | 1997000000 | JPY |
| Other ca | CurrentQuarterInstant | 2109000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -167000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -160000000 | JPY |
| Current assets | Prior1YearInstant | 48625000000 | JPY |
| Current assets | CurrentQuarterInstant | 50247000000 | JPY |
| Buildings and structures | Prior1YearInstant | 19718000000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 20432000000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -14305000000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -14753000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 5412000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 5678000000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 21468000000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 22601000000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -19927000000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -20742000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1540000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1859000000 | JPY |
| Land | Prior1YearInstant | 1025000000 | JPY |
| Land | CurrentQuarterInstant | 1099000000 | JPY |
| Lease assets ppe | Prior1YearInstant | 75000000 | JPY |
| Lease assets ppe | CurrentQuarterInstant | 84000000 | JPY |
| Accumulated depreciation lease assets ppe | Prior1YearInstant | -23000000 | JPY |
| Accumulated depreciation lease assets ppe | CurrentQuarterInstant | -26000000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 52000000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 58000000 | JPY |
| Construction in progress | Prior1YearInstant | 1524000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 1684000000 | JPY |
| Other ppe | Prior1YearInstant | 5377000000 | JPY |
| Other ppe | CurrentQuarterInstant | 5598000000 | JPY |
| Accumulated depreciation other ppe | Prior1YearInstant | -4911000000 | JPY |
| Accumulated depreciation other ppe | CurrentQuarterInstant | -5012000000 | JPY |
| Other net ppe | Prior1YearInstant | 465000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 586000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 10021000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 10967000000 | JPY |
| Goodwill | Prior1YearInstant | 2093000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2360000000 | JPY |
| Other ia | Prior1YearInstant | 832000000 | JPY |
| Other ia | CurrentQuarterInstant | 1185000000 | JPY |
| Intangible assets | Prior1YearInstant | 2926000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 3546000000 | JPY |
| Investment securities | Prior1YearInstant | 12733000000 | JPY |
| Investment securities | CurrentQuarterInstant | 11956000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 617000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 805000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |